From: Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing mice
Group | Dosage (g/kg) | IL-1β (pg/ml) | IL-2 (pg/ml) | TNF-α (pg/ml) |
---|---|---|---|---|
Control | 0 | 511.42 ± 6.06*# | 17.64 ± 0.99*# | 16.64 ± 0.86*# |
Model | 0 | 405.79 ± 7.03 | 15.23 ± 0.86 | 14.75 ± 0.67 |
CY | 0.02 | 447.58 ± 3.38 | 12.50 ± 0.92 | 13.53 ± 0.66 |
ASMq low | 2 | 430.50 ± 4.63*# | 17.15 ± 1.01*# | 18.52 ± 0.80*# |
ASMq medium | 4 | 510.32 ± 3.60*# | 23.55 ± 1.20*# | 27.13 ± 0.87*# |
ASMq high | 8 | 420.03 ± 3.06*# | 19.99 ± 1.27*# | 21.30 ± 0.87*# |